Drug information for GALANTAMINE HYDROBROMIDE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE, EXTENDED RELEASE; ORAL EQ 16MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine BARR 78189
2008-10-03 Letter

2008-09-19 Other Important Information from FDA
CAPSULE, EXTENDED RELEASE; ORAL EQ 24MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine BARR   "
CAPSULE, EXTENDED RELEASE; ORAL EQ 8MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine BARR   "
CAPSULE, EXTENDED RELEASE; ORAL EQ 16MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine IMPAX LABS 78484
CAPSULE, EXTENDED RELEASE; ORAL EQ 24MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine IMPAX LABS   "
CAPSULE, EXTENDED RELEASE; ORAL EQ 8MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine IMPAX LABS   "
CAPSULE, EXTENDED RELEASE; ORAL EQ 16MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine WATSON LABS 79028
CAPSULE, EXTENDED RELEASE; ORAL EQ 24MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine WATSON LABS   "
CAPSULE, EXTENDED RELEASE; ORAL EQ 8MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine WATSON LABS   "
CAPSULE, EXTENDED RELEASE; ORAL EQ 16MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine SUN PHARMA GLOBAL 90178
CAPSULE, EXTENDED RELEASE; ORAL EQ 24MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine SUN PHARMA GLOBAL   "
CAPSULE, EXTENDED RELEASE; ORAL EQ 8MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine SUN PHARMA GLOBAL   "
CAPSULE, EXTENDED RELEASE; ORAL EQ 16MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine MYLAN 90900
CAPSULE, EXTENDED RELEASE; ORAL EQ 24MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine MYLAN   "
CAPSULE, EXTENDED RELEASE; ORAL EQ 8MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine MYLAN   "
SOLUTION; ORAL 4MG/ML Prescription AA  GALANTAMINE HYDROBROMIDE Galantamine ROXANE 78185
2009-02-24 Label

2009-02-03 Letter
SOLUTION; ORAL 4MG/ML Tentative Approval   GALANTAMINE HYDROBROMIDE Galantamine RANBAXY 78495
2008-09-19 Other Important Information from FDA
TABLET; ORAL EQ 12MG BASE Discontinued   GALANTAMINE HYDROBROMIDE Galantamine ACTAVIS ELIZABETH 77585
TABLET; ORAL EQ 4MG BASE Discontinued   GALANTAMINE HYDROBROMIDE Galantamine ACTAVIS ELIZABETH   "
TABLET; ORAL EQ 8MG BASE Discontinued   GALANTAMINE HYDROBROMIDE Galantamine ACTAVIS ELIZABETH   "
TABLET; ORAL EQ 12MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine TEVA PHARMS 77587
TABLET; ORAL EQ 4MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine TEVA PHARMS   "
TABLET; ORAL EQ 8MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine TEVA PHARMS   "
TABLET; ORAL 12MG Tentative Approval   GALANTAMINE HYDROBROMIDE Galantamine RANBAXY 77588
TABLET; ORAL 4MG Tentative Approval   GALANTAMINE HYDROBROMIDE Galantamine RANBAXY   "
TABLET; ORAL 8MG Tentative Approval   GALANTAMINE HYDROBROMIDE Galantamine RANBAXY   "
TABLET; ORAL EQ 12MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine SANDOZ 77589
TABLET; ORAL EQ 4MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine SANDOZ   "
TABLET; ORAL EQ 8MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine SANDOZ   "
TABLET; ORAL EQ 12MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine MYLAN 77590
TABLET; ORAL EQ 4MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine MYLAN   "
TABLET; ORAL EQ 8MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine MYLAN   "
TABLET; ORAL 12MG Tentative Approval   GALANTAMINE HYDROBROMIDE Galantamine SUN PHARM INDS 77592
TABLET; ORAL 4MG Tentative Approval   GALANTAMINE HYDROBROMIDE Galantamine SUN PHARM INDS   "
TABLET; ORAL 8MG Tentative Approval   GALANTAMINE HYDROBROMIDE Galantamine SUN PHARM INDS   "
TABLET; ORAL EQ 12MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine DR REDDYS LABS LTD 77593
2008-09-19 Other Important Information from FDA
TABLET; ORAL EQ 4MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine DR REDDYS LABS LTD   "
TABLET; ORAL EQ 8MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine DR REDDYS LABS LTD   "
TABLET; ORAL EQ 12MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine MYLAN 77603
2008-09-19 Other Important Information from FDA

2008-08-29 Letter
TABLET; ORAL EQ 4MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine MYLAN   "
TABLET; ORAL EQ 8MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine MYLAN   "
TABLET; ORAL EQ 12MG BASE Discontinued   GALANTAMINE HYDROBROMIDE Galantamine YABAO BIOPHARMS 77604
TABLET; ORAL EQ 4MG BASE Discontinued   GALANTAMINE HYDROBROMIDE Galantamine YABAO BIOPHARMS   "
TABLET; ORAL EQ 8MG BASE Discontinued   GALANTAMINE HYDROBROMIDE Galantamine YABAO BIOPHARMS   "
TABLET; ORAL EQ 12MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine BARR 77605
2008-11-20 Label

2008-09-19 Other Important Information from FDA

2008-08-29 Letter
TABLET; ORAL EQ 4MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine BARR   "
TABLET; ORAL EQ 8MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine BARR   "
TABLET; ORAL EQ 12MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine ROXANE 77608
TABLET; ORAL EQ 4MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine ROXANE   "
TABLET; ORAL EQ 8MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine ROXANE   "
TABLET; ORAL EQ 12MG BASE Tentative Approval   GALANTAMINE HYDROBROMIDE Galantamine WATSON LABS 77767
TABLET; ORAL EQ 4MG BASE Tentative Approval   GALANTAMINE HYDROBROMIDE Galantamine WATSON LABS   "
TABLET; ORAL EQ 8MG BASE Tentative Approval   GALANTAMINE HYDROBROMIDE Galantamine WATSON LABS   "
TABLET; ORAL EQ 12MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine APOTEX INC 77781
TABLET; ORAL EQ 4MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine APOTEX INC   "
TABLET; ORAL EQ 8MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine APOTEX INC   "
TABLET; ORAL EQ 12MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine ZYDUS PHARMS USA INC 78898
TABLET; ORAL EQ 4MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine ZYDUS PHARMS USA INC   "
TABLET; ORAL EQ 8MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine ZYDUS PHARMS USA INC   "
TABLET; ORAL EQ 12MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine AUROBINDO PHARMA LTD 90957
TABLET; ORAL EQ 4MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine AUROBINDO PHARMA LTD   "
TABLET; ORAL EQ 8MG BASE Prescription AB  GALANTAMINE HYDROBROMIDE Galantamine AUROBINDO PHARMA LTD   "

Drug Adverse Effects information for GALANTAMINE HYDROBROMIDE

Role code Indications Reaction # Reports
PS ANXIETY HAEMOLYTIC ANAEMIA 4
PS ARRHYTHMIA CONTUSION 1
PS ARRHYTHMIA DEATH 1
PS ARRHYTHMIA DECREASED APPETITE 1
PS ARRHYTHMIA FALL 1
PS ATTENTION DEFICIT/HYPERACTIVITY DISORDER ANGER 3
PS ATTENTION DEFICIT/HYPERACTIVITY DISORDER COMMUNICATION DISORDER 3
PS ATTENTION DEFICIT/HYPERACTIVITY DISORDER DRUG INTERACTION 3
PS ATTENTION DEFICIT/HYPERACTIVITY DISORDER EXTRAPYRAMIDAL DISORDER 3
PS ATTENTION DEFICIT/HYPERACTIVITY DISORDER INCORRECT DOSE ADMINISTERED 3
PS ATTENTION DEFICIT/HYPERACTIVITY DISORDER SALIVARY HYPERSECRETION 3
PS ATTENTION DEFICIT/HYPERACTIVITY DISORDER TREMOR 3
PS BLOOD GLUCOSE ABNORMAL CHOLECYSTITIS ACUTE 3
PS BLOOD GLUCOSE ABNORMAL CHOLELITHIASIS 3
PS BLOOD PRESSURE CHOLECYSTITIS ACUTE 3
PS BLOOD PRESSURE CHOLELITHIASIS 3
PS CALCIUM DEFICIENCY HAEMOLYTIC ANAEMIA 4
PS CARDIAC FAILURE COGNITIVE DISORDER 3
PS CARDIAC FAILURE SLEEP APNOEA SYNDROME 3
PS CARDIAC FAILURE SOMNOLENCE 3
PS CEREBRAL INFARCTION CONTUSION 1
PS CEREBRAL INFARCTION DEATH 1
PS CEREBRAL INFARCTION DECREASED APPETITE 1
PS CEREBRAL INFARCTION FALL 1
PS CEREBRAL INFARCTION LOSS OF CONSCIOUSNESS 1
PS CEREBRAL INFARCTION TONIC CONVULSION 1
PS CONSTIPATION LOSS OF CONSCIOUSNESS 2
PS CONSTIPATION RHABDOMYOLYSIS 3
PS CONSTIPATION TONIC CONVULSION 2
PS CONSTIPATION URINARY TRACT INFECTION 3
PS DEMENTIA ALTERED STATE OF CONSCIOUSNESS 4
PS DEMENTIA ANXIETY 1
PS DEMENTIA AORTIC DISSECTION 1
PS DEMENTIA BLOOD PRESSURE INCREASED 4
PS DEMENTIA BRADYCARDIA 6
PS DEMENTIA CIRCULATORY COLLAPSE 6
PS DEMENTIA CONVULSION 6
PS DEMENTIA DECREASED APPETITE 3
PS DEMENTIA GAIT DISTURBANCE 6
PS DEMENTIA HALLUCINATION 1
PS DEMENTIA HALLUCINATION, TACTILE 1
PS DEMENTIA HYPERVIGILANCE 1
PS DEMENTIA HYPOPHAGIA 6
PS DEMENTIA HYPOTENSION 6
PS DEMENTIA INCORRECT DOSE ADMINISTERED 1
PS DEMENTIA LACRIMATION INCREASED 6
PS DEMENTIA LARGE INTESTINAL HAEMORRHAGE 6
PS DEMENTIA LOSS OF CONSCIOUSNESS 2
PS DEMENTIA MUSCLE SPASMS 4
PS DEMENTIA MUSCULAR WEAKNESS 6
PS DEMENTIA NAUSEA 6
PS DEMENTIA NORMAL PRESSURE HYDROCEPHALUS 1
PS DEMENTIA OEDEMA PERIPHERAL 4
PS DEMENTIA OVERDOSE 6
PS DEMENTIA PARKINSONISM 1
PS DEMENTIA PNEUMONIA 1
PS DEMENTIA PNEUMONIA ASPIRATION 3
PS DEMENTIA POOR QUALITY SLEEP 1
PS DEMENTIA PYREXIA 4
PS DEMENTIA RHABDOMYOLYSIS 3
PS DEMENTIA SALIVARY HYPERSECRETION 6
PS DEMENTIA STEVENS-JOHNSON SYNDROME 1
PS DEMENTIA THINKING ABNORMAL 6
PS DEMENTIA URINARY TRACT INFECTION 3
PS DEMENTIA URINE OUTPUT DECREASED 1
PS DEMENTIA VOMITING 10
PS DEMENTIA WEIGHT DECREASED 4
PS DEMENTIA ALZHEIMER'S TYPE ABDOMINAL PAIN 3
PS DEMENTIA ALZHEIMER'S TYPE ACCIDENTAL OVERDOSE 1
PS DEMENTIA ALZHEIMER'S TYPE ANGER 5
PS DEMENTIA ALZHEIMER'S TYPE ANXIETY 3
PS DEMENTIA ALZHEIMER'S TYPE ASTHENIA 1
PS DEMENTIA ALZHEIMER'S TYPE BRADYKINESIA 2
PS DEMENTIA ALZHEIMER'S TYPE CARDIAC FAILURE 5
PS DEMENTIA ALZHEIMER'S TYPE CEREBRAL INFARCTION 1
PS DEMENTIA ALZHEIMER'S TYPE CHOLECYSTITIS ACUTE 3
PS DEMENTIA ALZHEIMER'S TYPE CHOLELITHIASIS 3
PS DEMENTIA ALZHEIMER'S TYPE COGNITIVE DISORDER 1
PS DEMENTIA ALZHEIMER'S TYPE COMMUNICATION DISORDER 5
PS DEMENTIA ALZHEIMER'S TYPE CONTUSION 1
PS DEMENTIA ALZHEIMER'S TYPE DEATH 1
PS DEMENTIA ALZHEIMER'S TYPE DECREASED APPETITE 2
PS DEMENTIA ALZHEIMER'S TYPE DELUSION 3
PS DEMENTIA ALZHEIMER'S TYPE DIZZINESS 5
PS DEMENTIA ALZHEIMER'S TYPE DRUG INTERACTION 5
PS DEMENTIA ALZHEIMER'S TYPE DRUG PRESCRIBING ERROR 1
PS DEMENTIA ALZHEIMER'S TYPE EXTRAPYRAMIDAL DISORDER 6
PS DEMENTIA ALZHEIMER'S TYPE FALL 4
PS DEMENTIA ALZHEIMER'S TYPE FRACTURE 1
PS DEMENTIA ALZHEIMER'S TYPE GAIT DISTURBANCE 3
PS DEMENTIA ALZHEIMER'S TYPE HAEMOLYTIC ANAEMIA 12
PS DEMENTIA ALZHEIMER'S TYPE HALLUCINATION 3
PS DEMENTIA ALZHEIMER'S TYPE HOSPITALISATION 1
PS DEMENTIA ALZHEIMER'S TYPE HYPERTENSION 3
PS DEMENTIA ALZHEIMER'S TYPE INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3
PS DEMENTIA ALZHEIMER'S TYPE INCORRECT DOSE ADMINISTERED 7
PS DEMENTIA ALZHEIMER'S TYPE INJURY 1
PS DEMENTIA ALZHEIMER'S TYPE LOSS OF CONSCIOUSNESS 4
PS DEMENTIA ALZHEIMER'S TYPE MASKED FACIES 2
PS DEMENTIA ALZHEIMER'S TYPE MYOCLONUS 1
PS DEMENTIA ALZHEIMER'S TYPE NAUSEA 2
PS DEMENTIA ALZHEIMER'S TYPE NORMAL PRESSURE HYDROCEPHALUS 1
PS DEMENTIA ALZHEIMER'S TYPE PARKINSONIAN GAIT 2
PS DEMENTIA ALZHEIMER'S TYPE PARKINSONISM 1
PS DEMENTIA ALZHEIMER'S TYPE PNEUMONIA 1
PS DEMENTIA ALZHEIMER'S TYPE PORIOMANIA 1
PS DEMENTIA ALZHEIMER'S TYPE PRODUCT QUALITY ISSUE 1
PS DEMENTIA ALZHEIMER'S TYPE PULMONARY EMBOLISM 5
PS DEMENTIA ALZHEIMER'S TYPE RENAL NEOPLASM 1
PS DEMENTIA ALZHEIMER'S TYPE RESPIRATORY ARREST 3
PS DEMENTIA ALZHEIMER'S TYPE SALIVARY HYPERSECRETION 5
PS DEMENTIA ALZHEIMER'S TYPE SLEEP APNOEA SYNDROME 2
PS DEMENTIA ALZHEIMER'S TYPE SOMNOLENCE 2
PS DEMENTIA ALZHEIMER'S TYPE SPEECH DISORDER 3
PS DEMENTIA ALZHEIMER'S TYPE SYNCOPE 2
PS DEMENTIA ALZHEIMER'S TYPE TACHYCARDIA 1
PS DEMENTIA ALZHEIMER'S TYPE TONIC CONVULSION 6
PS DEMENTIA ALZHEIMER'S TYPE TREMOR 5
PS DEMENTIA ALZHEIMER'S TYPE URTICARIA 4
PS DEMENTIA ALZHEIMER'S TYPE VOMITING 8
PS DEPRESSION COGNITIVE DISORDER 1
PS DEPRESSION SLEEP APNOEA SYNDROME 1
PS DEPRESSION SOMNOLENCE 1
PS DEPRESSION URINE OUTPUT DECREASED 1
PS DIABETES MELLITUS NORMAL PRESSURE HYDROCEPHALUS 1
PS DIABETES MELLITUS PARKINSONISM 1
PS DIABETES MELLITUS PNEUMONIA 1
PS DYSLIPIDAEMIA NORMAL PRESSURE HYDROCEPHALUS 1
PS DYSLIPIDAEMIA PARKINSONISM 1
PS DYSLIPIDAEMIA PNEUMONIA 1
PS EPILEPSY HAEMOLYTIC ANAEMIA 4
PS GASTRIC ULCER NORMAL PRESSURE HYDROCEPHALUS 1
PS GASTRIC ULCER PARKINSONISM 1
PS GASTRIC ULCER PNEUMONIA 1
PS GASTROOESOPHAGEAL REFLUX DISEASE RHABDOMYOLYSIS 3
PS GASTROOESOPHAGEAL REFLUX DISEASE URINARY TRACT INFECTION 3
PS HALLUCINATION NEUROLEPTIC MALIGNANT SYNDROME 2
PS HEAD DISCOMFORT ACCIDENTAL OVERDOSE 1
PS HEAD DISCOMFORT ASTHENIA 1
PS HEAD DISCOMFORT DIZZINESS 1
PS HEAD DISCOMFORT FALL 1
PS HEAD DISCOMFORT FRACTURE 1
PS HEAD DISCOMFORT VOMITING 1
PS HEPATITIS C CONTUSION 1
PS HEPATITIS C DEATH 1
PS HEPATITIS C DECREASED APPETITE 1
PS HEPATITIS C FALL 1
PS HYPERLIPIDAEMIA STEVENS-JOHNSON SYNDROME 1
PS HYPERTENSION ACCIDENTAL OVERDOSE 1
PS HYPERTENSION ASTHENIA 1
PS HYPERTENSION COGNITIVE DISORDER 1
PS HYPERTENSION DIZZINESS 1
PS HYPERTENSION FALL 1
PS HYPERTENSION FRACTURE 1
PS HYPERTENSION NEUROLEPTIC MALIGNANT SYNDROME 2
PS HYPERTENSION RHABDOMYOLYSIS 3
PS HYPERTENSION SLEEP APNOEA SYNDROME 1
PS HYPERTENSION SOMNOLENCE 1
PS HYPERTENSION STEVENS-JOHNSON SYNDROME 1
PS HYPERTENSION URINARY TRACT INFECTION 3
PS HYPERTENSION VOMITING 1
PS HYPERURICAEMIA STEVENS-JOHNSON SYNDROME 1
PS INSOMNIA ANGER 1
PS INSOMNIA COMMUNICATION DISORDER 1
PS INSOMNIA DRUG INTERACTION 1
PS INSOMNIA EXTRAPYRAMIDAL DISORDER 1
PS INSOMNIA INCORRECT DOSE ADMINISTERED 1
PS INSOMNIA NEUROLEPTIC MALIGNANT SYNDROME 1
PS INSOMNIA SALIVARY HYPERSECRETION 1
PS INSOMNIA TREMOR 1
PS MEMORY IMPAIRMENT OFF LABEL USE 3
PS MEMORY IMPAIRMENT PSYCHOMOTOR HYPERACTIVITY 3
PS NEUROGENIC BLADDER LOSS OF CONSCIOUSNESS 1
PS NEUROGENIC BLADDER TONIC CONVULSION 1
PS OEDEMA PERIPHERAL ACCIDENTAL OVERDOSE 1
PS OEDEMA PERIPHERAL ASTHENIA 1
PS OEDEMA PERIPHERAL DIZZINESS 1
PS OEDEMA PERIPHERAL FALL 1
PS OEDEMA PERIPHERAL FRACTURE 1
PS OEDEMA PERIPHERAL VOMITING 1
PS OSTEOARTHRITIS ACCIDENTAL OVERDOSE 1
PS OSTEOARTHRITIS ASTHENIA 1
PS OSTEOARTHRITIS DIZZINESS 1
PS OSTEOARTHRITIS FALL 1
PS OSTEOARTHRITIS FRACTURE 1
PS OSTEOARTHRITIS VOMITING 1
PS OSTEOPOROSIS CONTUSION 1
PS OSTEOPOROSIS DEATH 1
PS OSTEOPOROSIS DECREASED APPETITE 1
PS OSTEOPOROSIS FALL 1
PS PARKINSONISM ATRIOVENTRICULAR BLOCK COMPLETE 1
PS PARKINSONISM CONVULSION 1
PS PARKINSONISM HALLUCINATION 1
PS PARKINSONISM OFF LABEL USE 3
PS PARKINSONISM PSYCHOMOTOR HYPERACTIVITY 3
PS PARKINSONISM PULSE ABSENT 1
PS PARKINSONISM RESTLESSNESS 1
PS PNEUMONIA LOSS OF CONSCIOUSNESS 2
PS PNEUMONIA TONIC CONVULSION 2
PS PRODUCT USED FOR UNKNOWN INDICATION ACCIDENTAL EXPOSURE 2
PS PRODUCT USED FOR UNKNOWN INDICATION ALTERED STATE OF CONSCIOUSNESS 4
PS PRODUCT USED FOR UNKNOWN INDICATION ANGER 6
PS PRODUCT USED FOR UNKNOWN INDICATION AORTIC DISSECTION 1
PS PRODUCT USED FOR UNKNOWN INDICATION BLOOD CREATINE PHOSPHOKINASE INCREASED 1
PS PRODUCT USED FOR UNKNOWN INDICATION BLOOD PRESSURE INCREASED 6
PS PRODUCT USED FOR UNKNOWN INDICATION BRADYCARDIA 8
PS PRODUCT USED FOR UNKNOWN INDICATION CARDIAC FAILURE 1
PS PRODUCT USED FOR UNKNOWN INDICATION CIRCULATORY COLLAPSE 6
PS PRODUCT USED FOR UNKNOWN INDICATION COMMUNICATION DISORDER 6
PS PRODUCT USED FOR UNKNOWN INDICATION CONVULSION 6
PS PRODUCT USED FOR UNKNOWN INDICATION DECREASED APPETITE 3
PS PRODUCT USED FOR UNKNOWN INDICATION DIET REFUSAL 2
PS PRODUCT USED FOR UNKNOWN INDICATION DRUG INTERACTION 6
PS PRODUCT USED FOR UNKNOWN INDICATION EXTRAPYRAMIDAL DISORDER 6
PS PRODUCT USED FOR UNKNOWN INDICATION FALL 3
PS PRODUCT USED FOR UNKNOWN INDICATION GAIT DISTURBANCE 6
PS PRODUCT USED FOR UNKNOWN INDICATION HAEMOLYTIC ANAEMIA 6
PS PRODUCT USED FOR UNKNOWN INDICATION HEADACHE 2
PS PRODUCT USED FOR UNKNOWN INDICATION HEAT STROKE 3
PS PRODUCT USED FOR UNKNOWN INDICATION HOSPITALISATION 2
PS PRODUCT USED FOR UNKNOWN INDICATION HYPOPHAGIA 6
PS PRODUCT USED FOR UNKNOWN INDICATION HYPOTENSION 6
PS PRODUCT USED FOR UNKNOWN INDICATION ILEUS 1
PS PRODUCT USED FOR UNKNOWN INDICATION INCORRECT DOSE ADMINISTERED 7
PS PRODUCT USED FOR UNKNOWN INDICATION INGUINAL HERNIA REPAIR 1
PS PRODUCT USED FOR UNKNOWN INDICATION INJURY 1
PS PRODUCT USED FOR UNKNOWN INDICATION INTERSTITIAL LUNG DISEASE 1
PS PRODUCT USED FOR UNKNOWN INDICATION LACRIMATION INCREASED 6
PS PRODUCT USED FOR UNKNOWN INDICATION LARGE INTESTINAL HAEMORRHAGE 6
PS PRODUCT USED FOR UNKNOWN INDICATION LOSS OF CONSCIOUSNESS 6
PS PRODUCT USED FOR UNKNOWN INDICATION MALAISE 1
PS PRODUCT USED FOR UNKNOWN INDICATION MULTIPLE DRUG OVERDOSE INTENTIONAL 3
PS PRODUCT USED FOR UNKNOWN INDICATION MUSCLE SPASMS 4
PS PRODUCT USED FOR UNKNOWN INDICATION MUSCULAR WEAKNESS 6
PS PRODUCT USED FOR UNKNOWN INDICATION MYOCLONUS 1
PS PRODUCT USED FOR UNKNOWN INDICATION NAUSEA 7
PS PRODUCT USED FOR UNKNOWN INDICATION NEUROLEPTIC MALIGNANT SYNDROME 1
PS PRODUCT USED FOR UNKNOWN INDICATION OEDEMA PERIPHERAL 4
PS PRODUCT USED FOR UNKNOWN INDICATION OVERDOSE 6
PS PRODUCT USED FOR UNKNOWN INDICATION POLLAKIURIA 2
PS PRODUCT USED FOR UNKNOWN INDICATION PORIOMANIA 1
PS PRODUCT USED FOR UNKNOWN INDICATION PSORIASIS 1
PS PRODUCT USED FOR UNKNOWN INDICATION PULMONARY EMBOLISM 2
PS PRODUCT USED FOR UNKNOWN INDICATION PYREXIA 4
PS PRODUCT USED FOR UNKNOWN INDICATION SALIVARY HYPERSECRETION 12
PS PRODUCT USED FOR UNKNOWN INDICATION SELF INJURIOUS BEHAVIOUR 3
PS PRODUCT USED FOR UNKNOWN INDICATION SYNCOPE 1
PS PRODUCT USED FOR UNKNOWN INDICATION THINKING ABNORMAL 6
PS PRODUCT USED FOR UNKNOWN INDICATION TREMOR 6
PS PRODUCT USED FOR UNKNOWN INDICATION VOMITING 11
PS PRODUCT USED FOR UNKNOWN INDICATION WEIGHT DECREASED 4
PS PRODUCT USED FOR UNKNOWN INDICATION WHITE BLOOD CELL COUNT DECREASED 2
PS SENILE DEMENTIA CHOLECYSTITIS ACUTE 3
PS SENILE DEMENTIA CHOLELITHIASIS 3
PS SENSATION OF HEAVINESS HAEMOLYTIC ANAEMIA 4
PS THROMBOSIS PROPHYLAXIS HAEMOLYTIC ANAEMIA 4
PS VASCULAR DEMENTIA CIRCULATORY COLLAPSE 1
PS VASCULAR DEMENTIA CONVULSION 2
PS VASCULAR DEMENTIA HYPOTHERMIA 2
PS VASCULAR DEMENTIA STATUS EPILEPTICUS 2
PS VASCULAR DEMENTIA SYNCOPE 2
PS VASCULAR DEMENTIA WHITE BLOOD CELL COUNT ABNORMAL 2
PS VITAMIN D DEFICIENCY HAEMOLYTIC ANAEMIA 4
SS ANXIETY HAEMOLYTIC ANAEMIA 3
SS ANXIETY NEUROLEPTIC MALIGNANT SYNDROME 1
SS ATTENTION DEFICIT/HYPERACTIVITY DISORDER ANGER 9
SS ATTENTION DEFICIT/HYPERACTIVITY DISORDER COMMUNICATION DISORDER 9
SS ATTENTION DEFICIT/HYPERACTIVITY DISORDER DRUG INTERACTION 9
SS ATTENTION DEFICIT/HYPERACTIVITY DISORDER EXTRAPYRAMIDAL DISORDER 9
SS ATTENTION DEFICIT/HYPERACTIVITY DISORDER INCORRECT DOSE ADMINISTERED 9
SS ATTENTION DEFICIT/HYPERACTIVITY DISORDER SALIVARY HYPERSECRETION 9
SS ATTENTION DEFICIT/HYPERACTIVITY DISORDER TREMOR 9
SS BLOOD GLUCOSE ABNORMAL CHOLECYSTITIS ACUTE 11
SS BLOOD GLUCOSE ABNORMAL CHOLELITHIASIS 11
SS BLOOD PRESSURE CHOLECYSTITIS ACUTE 11
SS BLOOD PRESSURE CHOLELITHIASIS 11
SS BONE DENSITY ABNORMAL NEUROLEPTIC MALIGNANT SYNDROME 1
SS CALCIUM DEFICIENCY ASTHENIA 1
SS CALCIUM DEFICIENCY HAEMOLYTIC ANAEMIA 6
SS CARDIAC FAILURE COGNITIVE DISORDER 3
SS CARDIAC FAILURE SLEEP APNOEA SYNDROME 3
SS CARDIAC FAILURE SOMNOLENCE 3
SS CATARACT NEUROLEPTIC MALIGNANT SYNDROME 2
SS COGNITIVE DISORDER NEUROLEPTIC MALIGNANT SYNDROME 1
SS CONSTIPATION RHABDOMYOLYSIS 3
SS CONSTIPATION URINARY TRACT INFECTION 3
SS DEMENTIA ALTERED STATE OF CONSCIOUSNESS 12
SS DEMENTIA BLOOD PRESSURE INCREASED 12
SS DEMENTIA BRADYCARDIA 18
SS DEMENTIA CIRCULATORY COLLAPSE 18
SS DEMENTIA CONVULSION 18
SS DEMENTIA GAIT DISTURBANCE 18
SS DEMENTIA HYPOPHAGIA 18
SS DEMENTIA HYPOTENSION 18
SS DEMENTIA LACRIMATION INCREASED 18
SS DEMENTIA LARGE INTESTINAL HAEMORRHAGE 18
SS DEMENTIA MUSCLE SPASMS 12
SS DEMENTIA MUSCULAR WEAKNESS 18
SS DEMENTIA NAUSEA 18
SS DEMENTIA NORMAL PRESSURE HYDROCEPHALUS 1
SS DEMENTIA OEDEMA PERIPHERAL 12
SS DEMENTIA OVERDOSE 18
SS DEMENTIA PARKINSONISM 1
SS DEMENTIA PNEUMONIA 1
SS DEMENTIA PYREXIA 12
SS DEMENTIA RHABDOMYOLYSIS 3
SS DEMENTIA SALIVARY HYPERSECRETION 18
SS DEMENTIA STEVENS-JOHNSON SYNDROME 1
SS DEMENTIA THINKING ABNORMAL 18
SS DEMENTIA URINARY TRACT INFECTION 3
SS DEMENTIA URINE OUTPUT DECREASED 1
SS DEMENTIA VOMITING 18
SS DEMENTIA WEIGHT DECREASED 12
SS DEMENTIA ALZHEIMER'S TYPE ABDOMINAL PAIN 3
SS DEMENTIA ALZHEIMER'S TYPE ANGER 15
SS DEMENTIA ALZHEIMER'S TYPE ASTHENIA 3
SS DEMENTIA ALZHEIMER'S TYPE CARDIAC FAILURE 5
SS DEMENTIA ALZHEIMER'S TYPE CHOLECYSTITIS ACUTE 11
SS DEMENTIA ALZHEIMER'S TYPE CHOLELITHIASIS 11
SS DEMENTIA ALZHEIMER'S TYPE COGNITIVE DISORDER 1
SS DEMENTIA ALZHEIMER'S TYPE COMMUNICATION DISORDER 15
SS DEMENTIA ALZHEIMER'S TYPE DRUG INTERACTION 15
SS DEMENTIA ALZHEIMER'S TYPE DRUG PRESCRIBING ERROR 2
SS DEMENTIA ALZHEIMER'S TYPE EXTRAPYRAMIDAL DISORDER 15
SS DEMENTIA ALZHEIMER'S TYPE HAEMOLYTIC ANAEMIA 18
SS DEMENTIA ALZHEIMER'S TYPE INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6
SS DEMENTIA ALZHEIMER'S TYPE INCORRECT DOSE ADMINISTERED 17
SS DEMENTIA ALZHEIMER'S TYPE NAUSEA 2
SS DEMENTIA ALZHEIMER'S TYPE NORMAL PRESSURE HYDROCEPHALUS 1
SS DEMENTIA ALZHEIMER'S TYPE PARKINSONISM 1
SS DEMENTIA ALZHEIMER'S TYPE PNEUMONIA 1
SS DEMENTIA ALZHEIMER'S TYPE PRODUCT QUALITY ISSUE 2
SS DEMENTIA ALZHEIMER'S TYPE PULMONARY EMBOLISM 4
SS DEMENTIA ALZHEIMER'S TYPE RENAL NEOPLASM 1
SS DEMENTIA ALZHEIMER'S TYPE RESPIRATORY ARREST 3
SS DEMENTIA ALZHEIMER'S TYPE SALIVARY HYPERSECRETION 15
SS DEMENTIA ALZHEIMER'S TYPE SLEEP APNOEA SYNDROME 1
SS DEMENTIA ALZHEIMER'S TYPE SOMNOLENCE 1
SS DEMENTIA ALZHEIMER'S TYPE SYNCOPE 2
SS DEMENTIA ALZHEIMER'S TYPE TACHYCARDIA 1
SS DEMENTIA ALZHEIMER'S TYPE TONIC CONVULSION 3
SS DEMENTIA ALZHEIMER'S TYPE TREMOR 15
SS DEMENTIA ALZHEIMER'S TYPE URTICARIA 4
SS DEMENTIA ALZHEIMER'S TYPE VOMITING 5
SS DEPRESSION COGNITIVE DISORDER 1
SS DEPRESSION SLEEP APNOEA SYNDROME 1
SS DEPRESSION SOMNOLENCE 1
SS DEPRESSION URINE OUTPUT DECREASED 1
SS DIABETES MELLITUS NORMAL PRESSURE HYDROCEPHALUS 1
SS DIABETES MELLITUS PARKINSONISM 1
SS DIABETES MELLITUS PNEUMONIA 1
SS DYSLIPIDAEMIA NORMAL PRESSURE HYDROCEPHALUS 1
SS DYSLIPIDAEMIA PARKINSONISM 1
SS DYSLIPIDAEMIA PNEUMONIA 1
SS EPILEPSY HAEMOLYTIC ANAEMIA 5
SS GASTRIC ULCER NORMAL PRESSURE HYDROCEPHALUS 1
SS GASTRIC ULCER PARKINSONISM 1
SS GASTRIC ULCER PNEUMONIA 1
SS GASTROOESOPHAGEAL REFLUX DISEASE RHABDOMYOLYSIS 3
SS GASTROOESOPHAGEAL REFLUX DISEASE URINARY TRACT INFECTION 3
SS HALLUCINATION NEUROLEPTIC MALIGNANT SYNDROME 3
SS HYPERLIPIDAEMIA STEVENS-JOHNSON SYNDROME 1
SS HYPERTENSION COGNITIVE DISORDER 1
SS HYPERTENSION NEUROLEPTIC MALIGNANT SYNDROME 2
SS HYPERTENSION RHABDOMYOLYSIS 3
SS HYPERTENSION SLEEP APNOEA SYNDROME 1
SS HYPERTENSION SOMNOLENCE 1
SS HYPERTENSION STEVENS-JOHNSON SYNDROME 1
SS HYPERTENSION URINARY TRACT INFECTION 3
SS HYPERURICAEMIA STEVENS-JOHNSON SYNDROME 1
SS INSOMNIA ANGER 3
SS INSOMNIA COMMUNICATION DISORDER 3
SS INSOMNIA DRUG INTERACTION 3
SS INSOMNIA EXTRAPYRAMIDAL DISORDER 3
SS INSOMNIA INCORRECT DOSE ADMINISTERED 3
SS INSOMNIA NEUROLEPTIC MALIGNANT SYNDROME 1
SS INSOMNIA SALIVARY HYPERSECRETION 3
SS INSOMNIA TREMOR 3
SS MEMORY IMPAIRMENT OFF LABEL USE 3
SS MEMORY IMPAIRMENT PSYCHOMOTOR HYPERACTIVITY 3
SS PARKINSONISM ATRIOVENTRICULAR BLOCK COMPLETE 1
SS PARKINSONISM CONVULSION 1
SS PARKINSONISM HALLUCINATION 1
SS PARKINSONISM OFF LABEL USE 3
SS PARKINSONISM PSYCHOMOTOR HYPERACTIVITY 3
SS PARKINSONISM PULSE ABSENT 1
SS PARKINSONISM RESTLESSNESS 1
SS PRODUCT USED FOR UNKNOWN INDICATION AGGRESSION 11
SS PRODUCT USED FOR UNKNOWN INDICATION ALTERED STATE OF CONSCIOUSNESS 12
SS PRODUCT USED FOR UNKNOWN INDICATION ANGER 18
SS PRODUCT USED FOR UNKNOWN INDICATION BLOOD CREATINE PHOSPHOKINASE INCREASED 1
SS PRODUCT USED FOR UNKNOWN INDICATION BLOOD PRESSURE INCREASED 12
SS PRODUCT USED FOR UNKNOWN INDICATION BRADYCARDIA 18
SS PRODUCT USED FOR UNKNOWN INDICATION CIRCULATORY COLLAPSE 18
SS PRODUCT USED FOR UNKNOWN INDICATION COMMUNICATION DISORDER 18
SS PRODUCT USED FOR UNKNOWN INDICATION CONVULSION 18
SS PRODUCT USED FOR UNKNOWN INDICATION DEATH 11
SS PRODUCT USED FOR UNKNOWN INDICATION DECREASED APPETITE 2
SS PRODUCT USED FOR UNKNOWN INDICATION DRUG INTERACTION 18
SS PRODUCT USED FOR UNKNOWN INDICATION EXTRAPYRAMIDAL DISORDER 18
SS PRODUCT USED FOR UNKNOWN INDICATION FEAR 11
SS PRODUCT USED FOR UNKNOWN INDICATION GAIT DISTURBANCE 18
SS PRODUCT USED FOR UNKNOWN INDICATION HOSPITALISATION 2
SS PRODUCT USED FOR UNKNOWN INDICATION HYPOPHAGIA 18
SS PRODUCT USED FOR UNKNOWN INDICATION HYPOTENSION 18
SS PRODUCT USED FOR UNKNOWN INDICATION IMPULSE-CONTROL DISORDER 11
SS PRODUCT USED FOR UNKNOWN INDICATION INCORRECT DOSE ADMINISTERED 19
SS PRODUCT USED FOR UNKNOWN INDICATION INGUINAL HERNIA REPAIR 1
SS PRODUCT USED FOR UNKNOWN INDICATION LACRIMATION INCREASED 18
SS PRODUCT USED FOR UNKNOWN INDICATION LARGE INTESTINAL HAEMORRHAGE 18
SS PRODUCT USED FOR UNKNOWN INDICATION MALAISE 1
SS PRODUCT USED FOR UNKNOWN INDICATION MUSCLE SPASMS 12
SS PRODUCT USED FOR UNKNOWN INDICATION MUSCULAR WEAKNESS 18
SS PRODUCT USED FOR UNKNOWN INDICATION NAUSEA 19
SS PRODUCT USED FOR UNKNOWN INDICATION NEUROLEPTIC MALIGNANT SYNDROME 3
SS PRODUCT USED FOR UNKNOWN INDICATION OEDEMA PERIPHERAL 12
SS PRODUCT USED FOR UNKNOWN INDICATION OVERDOSE 18
SS PRODUCT USED FOR UNKNOWN INDICATION PULMONARY EMBOLISM 2
SS PRODUCT USED FOR UNKNOWN INDICATION PYREXIA 12
SS PRODUCT USED FOR UNKNOWN INDICATION RESTLESSNESS 11
SS PRODUCT USED FOR UNKNOWN INDICATION SALIVARY HYPERSECRETION 36
SS PRODUCT USED FOR UNKNOWN INDICATION SYNCOPE 12
SS PRODUCT USED FOR UNKNOWN INDICATION THINKING ABNORMAL 18
SS PRODUCT USED FOR UNKNOWN INDICATION TREMOR 18
SS PRODUCT USED FOR UNKNOWN INDICATION VOMITING 18
SS PRODUCT USED FOR UNKNOWN INDICATION WEIGHT DECREASED 12
SS SENILE DEMENTIA CHOLECYSTITIS ACUTE 11
SS SENILE DEMENTIA CHOLELITHIASIS 11
SS SENSATION OF HEAVINESS ASTHENIA 1
SS SENSATION OF HEAVINESS HAEMOLYTIC ANAEMIA 6
SS THROMBOSIS PROPHYLAXIS HAEMOLYTIC ANAEMIA 5
SS VITAMIN D DEFICIENCY ASTHENIA 1
SS VITAMIN D DEFICIENCY HAEMOLYTIC ANAEMIA 6
C AMNESIA ATRIAL FIBRILLATION 1
C AMNESIA HEART RATE DECREASED 1
C AMNESIA HYPOTENSION 1
C AMNESIA SICK SINUS SYNDROME 1
C ANAEMIA VITAMIN B12 DEFICIENCY DEMENTIA ALZHEIMER'S TYPE 1
C ANAEMIA VITAMIN B12 DEFICIENCY DRUG INEFFECTIVE 1
C ANAEMIA VITAMIN B12 DEFICIENCY RHEUMATOID ARTHRITIS 1
C ANAL CANDIDIASIS ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5
C ANAL CANDIDIASIS DEHYDRATION 5
C ANAL CANDIDIASIS RENAL FAILURE 5
C ANXIETY ABNORMAL BEHAVIOUR 1
C ANXIETY AGGRESSION 1
C ANXIETY AGITATION 1
C ANXIETY HYPERTENSION 1
C ARRHYTHMIA APHASIA 1
C ARRHYTHMIA HEMIPARESIS 1
C ARRHYTHMIA ISCHAEMIC STROKE 1
C ARRHYTHMIA UNDERDOSE 1
C ARTHRITIS ABNORMAL BEHAVIOUR 1
C ARTHRITIS AGGRESSION 1
C ARTHRITIS AGITATION 1
C ARTHRITIS HYPERTENSION 1
C ATRIAL FIBRILLATION OEDEMA 1
C ATRIAL FIBRILLATION OEDEMA PERIPHERAL 1
C ATRIAL FIBRILLATION WEIGHT INCREASED 1
C BLOOD CHOLESTEROL ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 3
C BLOOD CHOLESTEROL BLINDNESS 3
C BLOOD CHOLESTEROL BRAIN INJURY 3
C BLOOD CHOLESTEROL HAEMORRHAGE 3
C BLOOD CHOLESTEROL INJECTION SITE INFECTION 3
C BLOOD CHOLESTEROL MENINGITIS 3
C BLOOD CHOLESTEROL MENINGOENCEPHALITIS BACTERIAL 3
C BLOOD CHOLESTEROL MENTAL STATUS CHANGES 3
C BLOOD CHOLESTEROL PAIN 3
C BLOOD CHOLESTEROL PRODUCT CONTAMINATION MICROBIAL 3
C BLOOD CHOLESTEROL PRODUCT QUALITY ISSUE 3
C BLOOD CHOLESTEROL TRANSMISSION OF AN INFECTIOUS AGENT VIA A MEDICINAL PRODUCT 1
C BLOOD CHOLESTEROL INCREASED ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4
C BLOOD CHOLESTEROL INCREASED DEHYDRATION 4
C BLOOD CHOLESTEROL INCREASED RENAL FAILURE 4
C BLOOD PRESSURE MANAGEMENT APPETITE DISORDER 1
C BLOOD PRESSURE MANAGEMENT ARTERIAL STENOSIS 1
C BLOOD PRESSURE MANAGEMENT ASTHENIA 1
C BLOOD PRESSURE MANAGEMENT BLOOD GLUCOSE INCREASED 1
C BLOOD PRESSURE MANAGEMENT BLOOD PRESSURE INCREASED 1
C BLOOD PRESSURE MANAGEMENT CARDIAC DISORDER 1
C BLOOD PRESSURE MANAGEMENT DIARRHOEA 1
C BLOOD PRESSURE MANAGEMENT DILATATION VENTRICULAR 1
C BLOOD PRESSURE MANAGEMENT FEELING ABNORMAL 1
C BLOOD PRESSURE MANAGEMENT FEELING COLD 1
C BLOOD PRESSURE MANAGEMENT HEART RATE INCREASED 1
C BLOOD PRESSURE MANAGEMENT HYPOGLYCAEMIA 1
C BLOOD PRESSURE MANAGEMENT INCORRECT DOSE ADMINISTERED 1
C BLOOD PRESSURE MANAGEMENT INFARCTION 1
C BLOOD PRESSURE MANAGEMENT MUSCULAR WEAKNESS 1
C BLOOD PRESSURE MANAGEMENT MYOCARDIAL ISCHAEMIA 1
C BLOOD PRESSURE MANAGEMENT PALLOR 1
C BLOOD PRESSURE MANAGEMENT PYREXIA 1
C BLOOD PRESSURE MANAGEMENT ROTAVIRUS INFECTION 1
C BLOOD PRESSURE MANAGEMENT SENSATION OF HEAVINESS 1
C CATHETERISATION CARDIAC ANHEDONIA 6
C CATHETERISATION CARDIAC ANXIETY 6
C CATHETERISATION CARDIAC DEATH 6
C CATHETERISATION CARDIAC EMOTIONAL DISTRESS 6
C CATHETERISATION CARDIAC FEAR 6
C CATHETERISATION CARDIAC INJURY 6
C CATHETERISATION CARDIAC MULTI-ORGAN FAILURE 6
C CATHETERISATION CARDIAC PAIN 6
C CATHETERISATION CARDIAC RENAL FAILURE 6
C CATHETERISATION CARDIAC RENAL IMPAIRMENT 6
C CATHETERISATION CARDIAC RENAL INJURY 6
C CATHETERISATION CARDIAC STRESS 6
C CATHETERISATION CARDIAC UNEVALUABLE EVENT 6
C CEREBROVASCULAR ACCIDENT PROPHYLAXIS ATRIAL FIBRILLATION 1
C CEREBROVASCULAR ACCIDENT PROPHYLAXIS HEART RATE DECREASED 1
C CEREBROVASCULAR ACCIDENT PROPHYLAXIS HYPOTENSION 1
C CEREBROVASCULAR ACCIDENT PROPHYLAXIS SICK SINUS SYNDROME 1
C CHOLINESTERASE INHIBITION ABNORMAL BEHAVIOUR 1
C CHOLINESTERASE INHIBITION AGGRESSION 1
C CHOLINESTERASE INHIBITION AGITATION 1
C CHOLINESTERASE INHIBITION HYPERTENSION 1
C CORONARY ARTERY BYPASS ANHEDONIA 4
C CORONARY ARTERY BYPASS ANXIETY 4
C CORONARY ARTERY BYPASS DEATH 4
C CORONARY ARTERY BYPASS EMOTIONAL DISTRESS 4
C CORONARY ARTERY BYPASS FEAR 4
C CORONARY ARTERY BYPASS INJURY 4
C CORONARY ARTERY BYPASS MULTI-ORGAN FAILURE 4
C CORONARY ARTERY BYPASS PAIN 4
C CORONARY ARTERY BYPASS RENAL FAILURE 4
C CORONARY ARTERY BYPASS RENAL IMPAIRMENT 4
C CORONARY ARTERY BYPASS RENAL INJURY 4
C CORONARY ARTERY BYPASS STRESS 4
C CORONARY ARTERY BYPASS UNEVALUABLE EVENT 4
C DEMENTIA ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4
C DEMENTIA DEHYDRATION 4
C DEMENTIA RENAL FAILURE 4
C DEMENTIA ALZHEIMER'S TYPE ABNORMAL BEHAVIOUR 1
C DEMENTIA ALZHEIMER'S TYPE ABULIA 2
C DEMENTIA ALZHEIMER'S TYPE AGGRESSION 1
C DEMENTIA ALZHEIMER'S TYPE AGITATION 1
C DEMENTIA ALZHEIMER'S TYPE ALANINE AMINOTRANSFERASE INCREASED 3
C DEMENTIA ALZHEIMER'S TYPE ASPARTATE AMINOTRANSFERASE INCREASED 1
C DEMENTIA ALZHEIMER'S TYPE BILIRUBIN CONJUGATED INCREASED 1
C DEMENTIA ALZHEIMER'S TYPE BLOOD ALKALINE PHOSPHATASE INCREASED 1
C DEMENTIA ALZHEIMER'S TYPE BLOOD BILIRUBIN UNCONJUGATED INCREASED 1
C DEMENTIA ALZHEIMER'S TYPE BLOOD GLUCOSE INCREASED 1
C DEMENTIA ALZHEIMER'S TYPE BLOOD POTASSIUM DECREASED 2
C DEMENTIA ALZHEIMER'S TYPE BLOOD PRESSURE INCREASED 2
C DEMENTIA ALZHEIMER'S TYPE DEMENTIA ALZHEIMER'S TYPE 6
C DEMENTIA ALZHEIMER'S TYPE DRUG INEFFECTIVE 6
C DEMENTIA ALZHEIMER'S TYPE GAMMA-GLUTAMYLTRANSFERASE INCREASED 1
C DEMENTIA ALZHEIMER'S TYPE GENERAL PHYSICAL HEALTH DETERIORATION 2
C DEMENTIA ALZHEIMER'S TYPE HAEMOGLOBIN DECREASED 1
C DEMENTIA ALZHEIMER'S TYPE HEART RATE DECREASED 2
C DEMENTIA ALZHEIMER'S TYPE HYPERTENSION 1
C DEMENTIA ALZHEIMER'S TYPE HYPOPHAGIA 2
C DEMENTIA ALZHEIMER'S TYPE MENTAL IMPAIRMENT 2
C DEMENTIA ALZHEIMER'S TYPE PLEURAL HAEMORRHAGE 1
C DEMENTIA ALZHEIMER'S TYPE PYREXIA 1
C DEMENTIA ALZHEIMER'S TYPE RHEUMATOID ARTHRITIS 6
C DEMENTIA ALZHEIMER'S TYPE SOMNOLENCE 3
C DEMENTIA ALZHEIMER'S TYPE ZINC SULPHATE TURBIDITY INCREASED 2
C DEPRESSION ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4
C DEPRESSION DEHYDRATION 4
C DEPRESSION RENAL FAILURE 4
C DIABETES MELLITUS APPETITE DISORDER 2
C DIABETES MELLITUS ARTERIAL STENOSIS 2
C DIABETES MELLITUS ASTHENIA 2
C DIABETES MELLITUS BLOOD GLUCOSE INCREASED 2
C DIABETES MELLITUS BLOOD PRESSURE INCREASED 2
C DIABETES MELLITUS CARDIAC DISORDER 2
C DIABETES MELLITUS DIARRHOEA 2
C DIABETES MELLITUS DILATATION VENTRICULAR 2
C DIABETES MELLITUS FEELING ABNORMAL 2
C DIABETES MELLITUS FEELING COLD 2
C DIABETES MELLITUS HEART RATE INCREASED 2
C DIABETES MELLITUS HYPOGLYCAEMIA 2
C DIABETES MELLITUS INCORRECT DOSE ADMINISTERED 2
C DIABETES MELLITUS INFARCTION 2
C DIABETES MELLITUS MUSCULAR WEAKNESS 2
C DIABETES MELLITUS MYOCARDIAL ISCHAEMIA 2
C DIABETES MELLITUS PALLOR 2
C DIABETES MELLITUS PYREXIA 2
C DIABETES MELLITUS ROTAVIRUS INFECTION 2
C DIABETES MELLITUS SENSATION OF HEAVINESS 2
C FATIGUE GASTROINTESTINAL HAEMORRHAGE 1
C FATIGUE HALLUCINATION 1
C FATIGUE HEPATIC CIRRHOSIS 1
C GASTRIC DISORDER DEMENTIA ALZHEIMER'S TYPE 3
C GASTRIC DISORDER DRUG INEFFECTIVE 3
C GASTRIC DISORDER GENERAL PHYSICAL HEALTH DETERIORATION 1
C GASTRIC DISORDER MENTAL IMPAIRMENT 1
C GASTRIC DISORDER RHEUMATOID ARTHRITIS 3
C GASTROOESOPHAGEAL REFLUX DISEASE ABNORMAL BEHAVIOUR 1
C GASTROOESOPHAGEAL REFLUX DISEASE AGGRESSION 1
C GASTROOESOPHAGEAL REFLUX DISEASE AGITATION 1
C GASTROOESOPHAGEAL REFLUX DISEASE HYPERTENSION 1
C GLAUCOMA ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 6
C GLAUCOMA BLINDNESS 6
C GLAUCOMA BRAIN INJURY 6
C GLAUCOMA HAEMORRHAGE 6
C GLAUCOMA INJECTION SITE INFECTION 6
C GLAUCOMA MENINGITIS 6
C GLAUCOMA MENINGOENCEPHALITIS BACTERIAL 6
C GLAUCOMA MENTAL STATUS CHANGES 6
C GLAUCOMA PAIN 6
C GLAUCOMA PRODUCT CONTAMINATION MICROBIAL 6
C GLAUCOMA PRODUCT QUALITY ISSUE 6
C GLAUCOMA TRANSMISSION OF AN INFECTIOUS AGENT VIA A MEDICINAL PRODUCT 2
C HYPERCHOLESTEROLAEMIA COMMUNICATION DISORDER 3
C HYPERCHOLESTEROLAEMIA DYSPHAGIA 3
C HYPERCHOLESTEROLAEMIA DYSPHONIA 3
C HYPERCHOLESTEROLAEMIA PLEURAL HAEMORRHAGE 1
C HYPERCHOLESTEROLAEMIA UNRESPONSIVE TO STIMULI 3
C HYPERLIPIDAEMIA ABNORMAL BEHAVIOUR 1
C HYPERLIPIDAEMIA AGGRESSION 1
C HYPERLIPIDAEMIA AGITATION 1
C HYPERLIPIDAEMIA HYPERTENSION 1
C HYPERTENSION ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 3
C HYPERTENSION BLINDNESS 3
C HYPERTENSION BRAIN INJURY 3
C HYPERTENSION HAEMORRHAGE 3
C HYPERTENSION INJECTION SITE INFECTION 3
C HYPERTENSION MENINGITIS 3
C HYPERTENSION MENINGOENCEPHALITIS BACTERIAL 3
C HYPERTENSION MENTAL STATUS CHANGES 3
C HYPERTENSION PAIN 3
C HYPERTENSION PNEUMONIA 2
C HYPERTENSION PRODUCT CONTAMINATION MICROBIAL 3
C HYPERTENSION PRODUCT QUALITY ISSUE 3
C HYPERTENSION TRANSMISSION OF AN INFECTIOUS AGENT VIA A MEDICINAL PRODUCT 1
C HYPOTHYROIDISM ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4
C HYPOTHYROIDISM DEHYDRATION 4
C HYPOTHYROIDISM RENAL FAILURE 4
C INFECTION ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 3
C INFECTION BLINDNESS 3
C INFECTION BRAIN INJURY 3
C INFECTION HAEMORRHAGE 3
C INFECTION INJECTION SITE INFECTION 3
C INFECTION MENINGITIS 3
C INFECTION MENINGOENCEPHALITIS BACTERIAL 3
C INFECTION MENTAL STATUS CHANGES 3
C INFECTION PAIN 3
C INFECTION PRODUCT CONTAMINATION MICROBIAL 3
C INFECTION PRODUCT QUALITY ISSUE 3
C INFECTION TRANSMISSION OF AN INFECTIOUS AGENT VIA A MEDICINAL PRODUCT 1
C INSOMNIA DEMENTIA ALZHEIMER'S TYPE 3
C INSOMNIA DRUG INEFFECTIVE 3
C INSOMNIA GENERAL PHYSICAL HEALTH DETERIORATION 1
C INSOMNIA MENTAL IMPAIRMENT 1
C INSOMNIA PLEURAL HAEMORRHAGE 1
C INSOMNIA RHEUMATOID ARTHRITIS 3
C MACULAR DEGENERATION ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 3
C MACULAR DEGENERATION BLINDNESS 3
C MACULAR DEGENERATION BRAIN INJURY 3
C MACULAR DEGENERATION HAEMORRHAGE 3
C MACULAR DEGENERATION INJECTION SITE INFECTION 3
C MACULAR DEGENERATION MENINGITIS 3
C MACULAR DEGENERATION MENINGOENCEPHALITIS BACTERIAL 3
C MACULAR DEGENERATION MENTAL STATUS CHANGES 3
C MACULAR DEGENERATION PAIN 3
C MACULAR DEGENERATION PRODUCT CONTAMINATION MICROBIAL 3
C MACULAR DEGENERATION PRODUCT QUALITY ISSUE 3
C MACULAR DEGENERATION TRANSMISSION OF AN INFECTIOUS AGENT VIA A MEDICINAL PRODUCT 1
C MEMORY IMPAIRMENT OEDEMA 1
C MEMORY IMPAIRMENT OEDEMA PERIPHERAL 1
C MEMORY IMPAIRMENT PNEUMONIA 1
C MEMORY IMPAIRMENT WEIGHT INCREASED 1
C MULTIPLE SCLEROSIS FEELING ABNORMAL 2
C MULTIPLE SCLEROSIS GASTRIC DISORDER 2
C MULTIPLE SCLEROSIS GASTROINTESTINAL HAEMORRHAGE 1
C MULTIPLE SCLEROSIS HALLUCINATION 1
C MULTIPLE SCLEROSIS HEPATIC CIRRHOSIS 1
C MULTIPLE SCLEROSIS INCONTINENCE 2
C MULTIPLE SCLEROSIS INTESTINAL OBSTRUCTION 2
C MULTIPLE SCLEROSIS OVERDOSE 2
C MULTIPLE SCLEROSIS PAIN 1
C MULTIPLE SCLEROSIS PAIN OF SKIN 2
C MULTIPLE SCLEROSIS SPINAL NERVE STIMULATOR IMPLANTATION 2
C MUSCLE SPASMS FEELING ABNORMAL 1
C MUSCLE SPASMS GASTRIC DISORDER 1
C MUSCLE SPASMS INCONTINENCE 1
C MUSCLE SPASMS INTESTINAL OBSTRUCTION 1
C MUSCLE SPASMS OVERDOSE 1
C MUSCLE SPASMS PAIN 1
C MUSCLE SPASMS PAIN OF SKIN 1
C MUSCLE SPASMS SPINAL NERVE STIMULATOR IMPLANTATION 1
C NARCOLEPSY PROSTATE CANCER 1
C OSTEOARTHRITIS ABNORMAL BEHAVIOUR 1
C OSTEOARTHRITIS AGGRESSION 1
C OSTEOARTHRITIS AGITATION 1
C OSTEOARTHRITIS HYPERTENSION 1
C OSTEOPOROSIS ABDOMINAL DISCOMFORT 1
C OSTEOPOROSIS ARTHRALGIA 1
C OSTEOPOROSIS ASTHENIA 1
C OSTEOPOROSIS BLISTER 1
C OSTEOPOROSIS CARDIAC PACEMAKER INSERTION 1
C OSTEOPOROSIS CARDIOVASCULAR DISORDER 1
C OSTEOPOROSIS CONSTIPATION 1
C OSTEOPOROSIS DEMENTIA ALZHEIMER'S TYPE 3
C OSTEOPOROSIS DISCOMFORT 1
C OSTEOPOROSIS DRUG INEFFECTIVE 3
C OSTEOPOROSIS GENERAL PHYSICAL HEALTH DETERIORATION 1
C OSTEOPOROSIS HYPOTENSION 1
C OSTEOPOROSIS JOINT SWELLING 1
C OSTEOPOROSIS MENTAL IMPAIRMENT 1
C OSTEOPOROSIS OEDEMA PERIPHERAL 1
C OSTEOPOROSIS PAIN 1
C OSTEOPOROSIS PAIN IN EXTREMITY 1
C OSTEOPOROSIS RESTLESS LEGS SYNDROME 1
C OSTEOPOROSIS RHEUMATOID ARTHRITIS 3
C OSTEOPOROSIS PROPHYLAXIS DEMENTIA ALZHEIMER'S TYPE 3
C OSTEOPOROSIS PROPHYLAXIS DRUG INEFFECTIVE 3
C OSTEOPOROSIS PROPHYLAXIS GENERAL PHYSICAL HEALTH DETERIORATION 1
C OSTEOPOROSIS PROPHYLAXIS MENTAL IMPAIRMENT 1
C OSTEOPOROSIS PROPHYLAXIS RHEUMATOID ARTHRITIS 3
C PAIN AGGRESSION 1
C PAIN AGITATION 1
C PAIN ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 3
C PAIN BLINDNESS 3
C PAIN BRAIN INJURY 3
C PAIN DEMENTIA 1
C PAIN DEMENTIA ALZHEIMER'S TYPE 8
C PAIN DRUG INEFFECTIVE 6
C PAIN FALL 2
C PAIN GASTROINTESTINAL HAEMORRHAGE 2
C PAIN GENERAL PHYSICAL HEALTH DETERIORATION 2
C PAIN HAEMORRHAGE 3
C PAIN HALLUCINATION 2
C PAIN HEPATIC CIRRHOSIS 2
C PAIN HEPATIC FUNCTION ABNORMAL 2
C PAIN IMPAIRED SELF-CARE 1
C PAIN INJECTION SITE INFECTION 3
C PAIN MENINGITIS 3
C PAIN MENINGOENCEPHALITIS BACTERIAL 3
C PAIN MENTAL IMPAIRMENT 2
C PAIN MENTAL STATUS CHANGES 3
C PAIN PAIN 3
C PAIN PRODUCT CONTAMINATION MICROBIAL 3
C PAIN PRODUCT QUALITY ISSUE 3
C PAIN RESTLESSNESS 1
C PAIN RHEUMATOID ARTHRITIS 6
C PAIN TRANSMISSION OF AN INFECTIOUS AGENT VIA A MEDICINAL PRODUCT 1
C PARKINSON'S DISEASE ATRIAL FIBRILLATION 1
C PARKINSON'S DISEASE HEART RATE DECREASED 1
C PARKINSON'S DISEASE HYPOTENSION 1
C PARKINSON'S DISEASE OEDEMA 1
C PARKINSON'S DISEASE OEDEMA PERIPHERAL 1
C PARKINSON'S DISEASE SICK SINUS SYNDROME 1
C PARKINSON'S DISEASE WEIGHT INCREASED 1
C PRODUCT USED FOR UNKNOWN INDICATION CONVERSION DISORDER 1
C PRODUCT USED FOR UNKNOWN INDICATION CRYING 1
C PRODUCT USED FOR UNKNOWN INDICATION DEMENTIA ALZHEIMER'S TYPE 10
C PRODUCT USED FOR UNKNOWN INDICATION DRUG INEFFECTIVE 9
C PRODUCT USED FOR UNKNOWN INDICATION DYSPNOEA 1
C PRODUCT USED FOR UNKNOWN INDICATION FALL 1
C PRODUCT USED FOR UNKNOWN INDICATION GENERAL PHYSICAL HEALTH DETERIORATION 3
C PRODUCT USED FOR UNKNOWN INDICATION HEADACHE 1
C PRODUCT USED FOR UNKNOWN INDICATION HEPATIC FUNCTION ABNORMAL 1
C PRODUCT USED FOR UNKNOWN INDICATION MENTAL IMPAIRMENT 3
C PRODUCT USED FOR UNKNOWN INDICATION PAIN IN EXTREMITY 1
C PRODUCT USED FOR UNKNOWN INDICATION PRURITUS 1
C PRODUCT USED FOR UNKNOWN INDICATION RHEUMATOID ARTHRITIS 9
C PRODUCT USED FOR UNKNOWN INDICATION URTICARIA 1
C PROMOTION OF PERIPHERAL CIRCULATION APPETITE DISORDER 2
C PROMOTION OF PERIPHERAL CIRCULATION ARTERIAL STENOSIS 2
C PROMOTION OF PERIPHERAL CIRCULATION ASTHENIA 2
C PROMOTION OF PERIPHERAL CIRCULATION BLOOD GLUCOSE INCREASED 2
C PROMOTION OF PERIPHERAL CIRCULATION BLOOD PRESSURE INCREASED 2
C PROMOTION OF PERIPHERAL CIRCULATION CARDIAC DISORDER 2
C PROMOTION OF PERIPHERAL CIRCULATION DIARRHOEA 2
C PROMOTION OF PERIPHERAL CIRCULATION DILATATION VENTRICULAR 2
C PROMOTION OF PERIPHERAL CIRCULATION FEELING ABNORMAL 2
C PROMOTION OF PERIPHERAL CIRCULATION FEELING COLD 2
C PROMOTION OF PERIPHERAL CIRCULATION HEART RATE INCREASED 2
C PROMOTION OF PERIPHERAL CIRCULATION HYPOGLYCAEMIA 2
C PROMOTION OF PERIPHERAL CIRCULATION INCORRECT DOSE ADMINISTERED 2
C PROMOTION OF PERIPHERAL CIRCULATION INFARCTION 2
C PROMOTION OF PERIPHERAL CIRCULATION MUSCULAR WEAKNESS 2
C PROMOTION OF PERIPHERAL CIRCULATION MYOCARDIAL ISCHAEMIA 2
C PROMOTION OF PERIPHERAL CIRCULATION PALLOR 2
C PROMOTION OF PERIPHERAL CIRCULATION PYREXIA 2
C PROMOTION OF PERIPHERAL CIRCULATION ROTAVIRUS INFECTION 2
C PROMOTION OF PERIPHERAL CIRCULATION SENSATION OF HEAVINESS 2
C PROPHYLAXIS APPETITE DISORDER 1
C PROPHYLAXIS ARTERIAL STENOSIS 1
C PROPHYLAXIS ASTHENIA 1
C PROPHYLAXIS BLOOD GLUCOSE INCREASED 1
C PROPHYLAXIS BLOOD PRESSURE INCREASED 1
C PROPHYLAXIS CARDIAC DISORDER 1
C PROPHYLAXIS DEMENTIA ALZHEIMER'S TYPE 3
C PROPHYLAXIS DIARRHOEA 1
C PROPHYLAXIS DILATATION VENTRICULAR 1
C PROPHYLAXIS DRUG INEFFECTIVE 3
C PROPHYLAXIS FEELING ABNORMAL 1
C PROPHYLAXIS FEELING COLD 1
C PROPHYLAXIS GENERAL PHYSICAL HEALTH DETERIORATION 1
C PROPHYLAXIS HEART RATE INCREASED 1
C PROPHYLAXIS HYPOGLYCAEMIA 1
C PROPHYLAXIS INCORRECT DOSE ADMINISTERED 1
C PROPHYLAXIS INFARCTION 1
C PROPHYLAXIS MENTAL IMPAIRMENT 1
C PROPHYLAXIS MUSCULAR WEAKNESS 1
C PROPHYLAXIS MYOCARDIAL ISCHAEMIA 1
C PROPHYLAXIS PALLOR 1
C PROPHYLAXIS PYREXIA 1
C PROPHYLAXIS RHEUMATOID ARTHRITIS 3
C PROPHYLAXIS ROTAVIRUS INFECTION 1
C PROPHYLAXIS SENSATION OF HEAVINESS 1
C PRURITUS FEELING ABNORMAL 1
C PRURITUS GASTRIC DISORDER 1
C PRURITUS INCONTINENCE 1
C PRURITUS INTESTINAL OBSTRUCTION 1
C PRURITUS OVERDOSE 1
C PRURITUS PAIN 1
C PRURITUS PAIN OF SKIN 1
C PRURITUS SPINAL NERVE STIMULATOR IMPLANTATION 1
C PYREXIA APPETITE DISORDER 1
C PYREXIA ARTERIAL STENOSIS 1
C PYREXIA ASTHENIA 1
C PYREXIA BLOOD GLUCOSE INCREASED 1
C PYREXIA BLOOD PRESSURE INCREASED 1
C PYREXIA CARDIAC DISORDER 1
C PYREXIA DIARRHOEA 1
C PYREXIA DILATATION VENTRICULAR 1
C PYREXIA FEELING ABNORMAL 1
C PYREXIA FEELING COLD 1
C PYREXIA HEART RATE INCREASED 1
C PYREXIA HYPOGLYCAEMIA 1
C PYREXIA INCORRECT DOSE ADMINISTERED 1
C PYREXIA INFARCTION 1
C PYREXIA MUSCULAR WEAKNESS 1
C PYREXIA MYOCARDIAL ISCHAEMIA 1
C PYREXIA PALLOR 1
C PYREXIA PYREXIA 1
C PYREXIA ROTAVIRUS INFECTION 1
C PYREXIA SENSATION OF HEAVINESS 1
C RHEUMATOID ARTHRITIS DEMENTIA ALZHEIMER'S TYPE 3
C RHEUMATOID ARTHRITIS DRUG INEFFECTIVE 3
C RHEUMATOID ARTHRITIS GENERAL PHYSICAL HEALTH DETERIORATION 1
C RHEUMATOID ARTHRITIS MENTAL IMPAIRMENT 1
C RHEUMATOID ARTHRITIS PNEUMONIA 3
C RHEUMATOID ARTHRITIS RHEUMATOID ARTHRITIS 3
C THROMBOEMBOLECTOMY ANHEDONIA 4
C THROMBOEMBOLECTOMY ANXIETY 4
C THROMBOEMBOLECTOMY DEATH 4
C THROMBOEMBOLECTOMY EMOTIONAL DISTRESS 4
C THROMBOEMBOLECTOMY FEAR 4
C THROMBOEMBOLECTOMY INJURY 4
C THROMBOEMBOLECTOMY MULTI-ORGAN FAILURE 4
C THROMBOEMBOLECTOMY PAIN 4
C THROMBOEMBOLECTOMY RENAL FAILURE 4
C THROMBOEMBOLECTOMY RENAL IMPAIRMENT 4
C THROMBOEMBOLECTOMY RENAL INJURY 4
C THROMBOEMBOLECTOMY STRESS 4
C THROMBOEMBOLECTOMY UNEVALUABLE EVENT 4
C TYPE 2 DIABETES MELLITUS APPETITE DISORDER 2
C TYPE 2 DIABETES MELLITUS ARTERIAL STENOSIS 2
C TYPE 2 DIABETES MELLITUS ASTHENIA 2
C TYPE 2 DIABETES MELLITUS BLOOD GLUCOSE INCREASED 2
C TYPE 2 DIABETES MELLITUS BLOOD PRESSURE INCREASED 2
C TYPE 2 DIABETES MELLITUS CARDIAC DISORDER 2
C TYPE 2 DIABETES MELLITUS DIARRHOEA 2
C TYPE 2 DIABETES MELLITUS DILATATION VENTRICULAR 2
C TYPE 2 DIABETES MELLITUS FEELING ABNORMAL 2
C TYPE 2 DIABETES MELLITUS FEELING COLD 2
C TYPE 2 DIABETES MELLITUS HEART RATE INCREASED 2
C TYPE 2 DIABETES MELLITUS HYPOGLYCAEMIA 2
C TYPE 2 DIABETES MELLITUS INCORRECT DOSE ADMINISTERED 2
C TYPE 2 DIABETES MELLITUS INFARCTION 2
C TYPE 2 DIABETES MELLITUS MUSCULAR WEAKNESS 2
C TYPE 2 DIABETES MELLITUS MYOCARDIAL ISCHAEMIA 2
C TYPE 2 DIABETES MELLITUS PALLOR 2
C TYPE 2 DIABETES MELLITUS PYREXIA 2
C TYPE 2 DIABETES MELLITUS ROTAVIRUS INFECTION 2
C TYPE 2 DIABETES MELLITUS SENSATION OF HEAVINESS 2
C UNEVALUABLE EVENT ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 1
C UNEVALUABLE EVENT BLINDNESS 1
C UNEVALUABLE EVENT BRAIN INJURY 1
C UNEVALUABLE EVENT HAEMORRHAGE 1
C UNEVALUABLE EVENT INJECTION SITE INFECTION 1
C UNEVALUABLE EVENT MENINGITIS 1
C UNEVALUABLE EVENT MENINGOENCEPHALITIS BACTERIAL 1
C UNEVALUABLE EVENT MENTAL STATUS CHANGES 1
C UNEVALUABLE EVENT PAIN 1
C UNEVALUABLE EVENT PRODUCT CONTAMINATION MICROBIAL 1
C UNEVALUABLE EVENT PRODUCT QUALITY ISSUE 1
C VITAMIN B12 DEFICIENCY DEMENTIA ALZHEIMER'S TYPE 2
C VITAMIN B12 DEFICIENCY DRUG INEFFECTIVE 2
C VITAMIN B12 DEFICIENCY GENERAL PHYSICAL HEALTH DETERIORATION 1
C VITAMIN B12 DEFICIENCY MENTAL IMPAIRMENT 1
C VITAMIN B12 DEFICIENCY RHEUMATOID ARTHRITIS 2
C VULVOVAGINAL CANDIDIASIS ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2
C VULVOVAGINAL CANDIDIASIS DEHYDRATION 2
C VULVOVAGINAL CANDIDIASIS RENAL FAILURE 2
Ads by Google